181 related articles for article (PubMed ID: 9752341)
1. [Update on tumor immunology].
Fridman WH; Berger A; Lee RS; Tartour E
Bull Cancer; 1998 Jan; 85(1):29-30. PubMed ID: 9752341
[No Abstract] [Full Text] [Related]
2. [MUC1, a therapeutic target in oncology].
Limacher JM; Acres B
Bull Cancer; 2007 Mar; 94(3):253-7. PubMed ID: 17371767
[TBL] [Abstract][Full Text] [Related]
3. The roles of heat shock proteins in tumor immunity.
Li Z
Cancer Chemother Biol Response Modif; 2001; 19():371-83. PubMed ID: 11686024
[No Abstract] [Full Text] [Related]
4. Cancer vaccines.
Dalgleish AG
Br J Cancer; 2000 May; 82(10):1619-24. PubMed ID: 10817493
[No Abstract] [Full Text] [Related]
5. [The function of tumor specific antigen (MAGE) in tumor immunotherapy].
Fang JB; Wang L
Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835
[No Abstract] [Full Text] [Related]
6. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
7. Researcher makes breakthrough in cancer research.
Expert Rev Anticancer Ther; 2002 Feb; 2(1):7. PubMed ID: 12113070
[No Abstract] [Full Text] [Related]
8. Cancer-testis antigens: targets for cancer immunotherapy.
Chen YT; Old LJ
Cancer J Sci Am; 1999; 5(1):16-7. PubMed ID: 10188055
[No Abstract] [Full Text] [Related]
9. Guest editorial: Cancer immunology.
Yasukawa M
Int J Hematol; 2011 Mar; 93(3):261-262. PubMed ID: 21347643
[No Abstract] [Full Text] [Related]
10. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
11. Cancer vaccines and immunotherapies: emerging perspectives.
Henderson RA; Mossman S; Nairn N; Cheever MA
Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
[TBL] [Abstract][Full Text] [Related]
12. Vaccine therapy for cancer--fact or fiction?
Evans TR; Kaye SB
QJM; 1999 Jun; 92(6):299-307. PubMed ID: 10616705
[No Abstract] [Full Text] [Related]
13. Tumor immunology at the service of cancer immunotherapy.
Finn OJ
Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
[No Abstract] [Full Text] [Related]
14. Tumor antigens as surrogate markers and targets for therapy and vaccines.
Dalgleish A; Pandha H
Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
[TBL] [Abstract][Full Text] [Related]
15. Are vaccines making a comeback in non-small-cell lung cancer?
Nemunaitis JJ
J Clin Oncol; 2008 Mar; 26(9):1402-3. PubMed ID: 18349390
[No Abstract] [Full Text] [Related]
16. [General principles and first clinical trials of therapeutic vaccines against cancer].
Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N
Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413
[TBL] [Abstract][Full Text] [Related]
17. Cancer vaccines: training the immune system to fight cancer.
Meadows M
FDA Consum; 2004; 38(5):20-5. PubMed ID: 15595145
[No Abstract] [Full Text] [Related]
18. [Tumor antigens].
Tiuriaeva II
Tsitologiia; 2008; 50(3):189-209. PubMed ID: 18664121
[TBL] [Abstract][Full Text] [Related]
19. Animal models of tumor immunity, immunotherapy and cancer vaccines.
Ostrand-Rosenberg S
Curr Opin Immunol; 2004 Apr; 16(2):143-50. PubMed ID: 15023405
[TBL] [Abstract][Full Text] [Related]
20. Vaccine therapy for cancer: fact or fiction?
Odunsi K; Lele S; Savalgi R
Surg Technol Int; 2004; 13():39-47. PubMed ID: 15744673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
